サマリー

ヒト二倍体細胞性狂犬病ワクチンの世界市場規模は、2022年の100万米ドルから2029年には100万米ドルになると予測されており、2023年から2029年までのCAGRは%であると予想されています。
ヒト二倍体細胞性狂犬病ワクチンの米国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると予測されています。
ヒト型二倍体細胞狂犬病ワクチンの中国市場は、2023年から2029年にかけてのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
ヒト二倍体細胞性狂犬病ワクチンのヨーロッパ市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されています。
世界の主要なヒト二倍体細胞性狂犬病ワクチンプレーヤーは、Chengdu Kanghua、Wyeth Laboratories、Beijing Kangtai Biology、Sanofi Pasteur SA、Merieux Institute、Kanghua Biologyなどです。収益面では、2022年に世界の2大企業がほぼ％のシェアを占めています。
狂犬病は、狂犬病ウイルスによって引き起こされる急性感染症である。臨床的に有効な治療法はありません。狂犬病は、臨床的に有効な治療法がなく、曝露後にワクチン接種を行うことで、狂犬病ウイルスに対する免疫の産生を促し、狂犬病の予防につなげることができます。
LPI（エルピーアイ）の最新リサーチレポート「ヒト型二倍体細胞狂犬病ワクチン産業予測」は、過去の販売実績から2022年の世界のヒト型二倍体細胞狂犬病ワクチンの総販売実績を検証し、2023年から2029年のヒト型二倍体細胞狂犬病ワクチン販売予測について地域や市場分野ごとに包括的に分析しています。本レポートでは、Human Diploid Cellular Rabies Vaccineの売上を地域別、市場分野別、サブセクター別に分類し、世界のHuman Diploid Cellular Rabies Vaccine産業の詳細な分析（百万米ドル単位）を提供します。
本インサイトレポートでは、世界のHuman Diploid Cellular Rabies Vaccineの状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにします。また、本レポートでは、加速する世界のHuman Diploid Cellular Rabies Vaccine市場におけるこれらの企業の独自のポジションをより理解するために、Human Diploid Cellular Rabies Vaccineのポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てて、主要グローバル企業の戦略を分析しています。
本インサイトレポートでは、Human Diploid Cellular Rabies Vaccineの世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、アプリケーション別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、この調査予測は、世界のHuman Diploid Cellular Rabies Vaccineの現状と将来の軌道について非常にニュアンスのある見方を提供します。
本レポートでは、Human Diploid Cellular Rabies Vaccine市場の製品タイプ、用途、主要メーカー、主要地域、国別の包括的な概要、市場シェア、成長機会について紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
0.5ml
1ミリリットル
用途別セグメンテーション
病院
診療所
また、本レポートでは、地域別に市場を分割しています：
米州
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
中近東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選ばれています。
成都康華（Chengdu Kanghua
ワイス・ラボラトリーズ
北京康泰生物学有限公司（Beijing Kangtai Biology
サノフィパスツールSA
メリュー研究所
カンフアバイオロジー
本レポートで取り上げる主な質問
世界のヒト二倍体細胞性狂犬病ワクチン市場の10年後の展望は？
世界および地域別に、ヒト2倍体細胞性狂犬病ワクチン市場の成長を促進する要因は何か？
市場別、地域別で最も速い成長を遂げる技術は何か？
ヒト型二倍体細胞性狂犬病ワクチンの市場機会は、エンドマーケットの規模によってどのように変化するのか？
Human Diploid Cellular Rabies Vaccineのタイプ別、用途別の内訳は？
COVID-19とロシア・ウクライナ戦争の影響とは？

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Diploid Cellular Rabies Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Human Diploid Cellular Rabies Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Human Diploid Cellular Rabies Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Human Diploid Cellular Rabies Vaccine Segment by Type
2.2.1 0.5ml
2.2.2 1ml
2.3 Human Diploid Cellular Rabies Vaccine Sales by Type
2.3.1 Global Human Diploid Cellular Rabies Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Human Diploid Cellular Rabies Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Human Diploid Cellular Rabies Vaccine Sale Price by Type (2018-2023)
2.4 Human Diploid Cellular Rabies Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Human Diploid Cellular Rabies Vaccine Sales by Application
2.5.1 Global Human Diploid Cellular Rabies Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Human Diploid Cellular Rabies Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Human Diploid Cellular Rabies Vaccine Sale Price by Application (2018-2023)
3 Global Human Diploid Cellular Rabies Vaccine by Company
3.1 Global Human Diploid Cellular Rabies Vaccine Breakdown Data by Company
3.1.1 Global Human Diploid Cellular Rabies Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Human Diploid Cellular Rabies Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Human Diploid Cellular Rabies Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Human Diploid Cellular Rabies Vaccine Revenue by Company (2018-2023)
3.2.2 Global Human Diploid Cellular Rabies Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Human Diploid Cellular Rabies Vaccine Sale Price by Company
3.4 Key Manufacturers Human Diploid Cellular Rabies Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Diploid Cellular Rabies Vaccine Product Location Distribution
3.4.2 Players Human Diploid Cellular Rabies Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Diploid Cellular Rabies Vaccine by Geographic Region
4.1 World Historic Human Diploid Cellular Rabies Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Human Diploid Cellular Rabies Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Human Diploid Cellular Rabies Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Human Diploid Cellular Rabies Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Human Diploid Cellular Rabies Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Human Diploid Cellular Rabies Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Human Diploid Cellular Rabies Vaccine Sales Growth
4.4 APAC Human Diploid Cellular Rabies Vaccine Sales Growth
4.5 Europe Human Diploid Cellular Rabies Vaccine Sales Growth
4.6 Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Growth
5 Americas
5.1 Americas Human Diploid Cellular Rabies Vaccine Sales by Country
5.1.1 Americas Human Diploid Cellular Rabies Vaccine Sales by Country (2018-2023)
5.1.2 Americas Human Diploid Cellular Rabies Vaccine Revenue by Country (2018-2023)
5.2 Americas Human Diploid Cellular Rabies Vaccine Sales by Type
5.3 Americas Human Diploid Cellular Rabies Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Diploid Cellular Rabies Vaccine Sales by Region
6.1.1 APAC Human Diploid Cellular Rabies Vaccine Sales by Region (2018-2023)
6.1.2 APAC Human Diploid Cellular Rabies Vaccine Revenue by Region (2018-2023)
6.2 APAC Human Diploid Cellular Rabies Vaccine Sales by Type
6.3 APAC Human Diploid Cellular Rabies Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Diploid Cellular Rabies Vaccine by Country
7.1.1 Europe Human Diploid Cellular Rabies Vaccine Sales by Country (2018-2023)
7.1.2 Europe Human Diploid Cellular Rabies Vaccine Revenue by Country (2018-2023)
7.2 Europe Human Diploid Cellular Rabies Vaccine Sales by Type
7.3 Europe Human Diploid Cellular Rabies Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Diploid Cellular Rabies Vaccine by Country
8.1.1 Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Human Diploid Cellular Rabies Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales by Type
8.3 Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Diploid Cellular Rabies Vaccine
10.3 Manufacturing Process Analysis of Human Diploid Cellular Rabies Vaccine
10.4 Industry Chain Structure of Human Diploid Cellular Rabies Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Diploid Cellular Rabies Vaccine Distributors
11.3 Human Diploid Cellular Rabies Vaccine Customer
12 World Forecast Review for Human Diploid Cellular Rabies Vaccine by Geographic Region
12.1 Global Human Diploid Cellular Rabies Vaccine Market Size Forecast by Region
12.1.1 Global Human Diploid Cellular Rabies Vaccine Forecast by Region (2024-2029)
12.1.2 Global Human Diploid Cellular Rabies Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Diploid Cellular Rabies Vaccine Forecast by Type
12.7 Global Human Diploid Cellular Rabies Vaccine Forecast by Application
13 Key Players Analysis
13.1 Chengdu Kanghua
13.1.1 Chengdu Kanghua Company Information
13.1.2 Chengdu Kanghua Human Diploid Cellular Rabies Vaccine Product Portfolios and Specifications
13.1.3 Chengdu Kanghua Human Diploid Cellular Rabies Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Chengdu Kanghua Main Business Overview
13.1.5 Chengdu Kanghua Latest Developments
13.2 Wyeth Laboratories
13.2.1 Wyeth Laboratories Company Information
13.2.2 Wyeth Laboratories Human Diploid Cellular Rabies Vaccine Product Portfolios and Specifications
13.2.3 Wyeth Laboratories Human Diploid Cellular Rabies Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Wyeth Laboratories Main Business Overview
13.2.5 Wyeth Laboratories Latest Developments
13.3 Beijing Kangtai Biology
13.3.1 Beijing Kangtai Biology Company Information
13.3.2 Beijing Kangtai Biology Human Diploid Cellular Rabies Vaccine Product Portfolios and Specifications
13.3.3 Beijing Kangtai Biology Human Diploid Cellular Rabies Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Beijing Kangtai Biology Main Business Overview
13.3.5 Beijing Kangtai Biology Latest Developments
13.4 Sanofi Pasteur SA
13.4.1 Sanofi Pasteur SA Company Information
13.4.2 Sanofi Pasteur SA Human Diploid Cellular Rabies Vaccine Product Portfolios and Specifications
13.4.3 Sanofi Pasteur SA Human Diploid Cellular Rabies Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sanofi Pasteur SA Main Business Overview
13.4.5 Sanofi Pasteur SA Latest Developments
13.5 Merieux Institute
13.5.1 Merieux Institute Company Information
13.5.2 Merieux Institute Human Diploid Cellular Rabies Vaccine Product Portfolios and Specifications
13.5.3 Merieux Institute Human Diploid Cellular Rabies Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merieux Institute Main Business Overview
13.5.5 Merieux Institute Latest Developments
13.6 Kanghua Biology
13.6.1 Kanghua Biology Company Information
13.6.2 Kanghua Biology Human Diploid Cellular Rabies Vaccine Product Portfolios and Specifications
13.6.3 Kanghua Biology Human Diploid Cellular Rabies Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Kanghua Biology Main Business Overview
13.6.5 Kanghua Biology Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. Human Diploid Cellular Rabies Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Human Diploid Cellular Rabies Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 0.5ml
Table 4. Major Players of 1ml
Table 5. Global Human Diploid Cellular Rabies Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Human Diploid Cellular Rabies Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Human Diploid Cellular Rabies Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Human Diploid Cellular Rabies Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Human Diploid Cellular Rabies Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Human Diploid Cellular Rabies Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Human Diploid Cellular Rabies Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Human Diploid Cellular Rabies Vaccine Revenue by Application (2018-2023)
Table 13. Global Human Diploid Cellular Rabies Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Human Diploid Cellular Rabies Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Human Diploid Cellular Rabies Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Human Diploid Cellular Rabies Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Human Diploid Cellular Rabies Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Human Diploid Cellular Rabies Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Human Diploid Cellular Rabies Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Human Diploid Cellular Rabies Vaccine Producing Area Distribution and Sales Area
Table 21. Players Human Diploid Cellular Rabies Vaccine Products Offered
Table 22. Human Diploid Cellular Rabies Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Human Diploid Cellular Rabies Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Human Diploid Cellular Rabies Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Human Diploid Cellular Rabies Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Human Diploid Cellular Rabies Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Human Diploid Cellular Rabies Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Human Diploid Cellular Rabies Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Human Diploid Cellular Rabies Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Human Diploid Cellular Rabies Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Human Diploid Cellular Rabies Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Human Diploid Cellular Rabies Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Human Diploid Cellular Rabies Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Human Diploid Cellular Rabies Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Human Diploid Cellular Rabies Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Human Diploid Cellular Rabies Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Human Diploid Cellular Rabies Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Human Diploid Cellular Rabies Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Human Diploid Cellular Rabies Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Human Diploid Cellular Rabies Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Human Diploid Cellular Rabies Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Human Diploid Cellular Rabies Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Human Diploid Cellular Rabies Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Human Diploid Cellular Rabies Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Human Diploid Cellular Rabies Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Human Diploid Cellular Rabies Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Human Diploid Cellular Rabies Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Human Diploid Cellular Rabies Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Human Diploid Cellular Rabies Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Human Diploid Cellular Rabies Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Human Diploid Cellular Rabies Vaccine
Table 58. Key Market Challenges & Risks of Human Diploid Cellular Rabies Vaccine
Table 59. Key Industry Trends of Human Diploid Cellular Rabies Vaccine
Table 60. Human Diploid Cellular Rabies Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Human Diploid Cellular Rabies Vaccine Distributors List
Table 63. Human Diploid Cellular Rabies Vaccine Customer List
Table 64. Global Human Diploid Cellular Rabies Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Human Diploid Cellular Rabies Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Human Diploid Cellular Rabies Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Human Diploid Cellular Rabies Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Human Diploid Cellular Rabies Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Human Diploid Cellular Rabies Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Human Diploid Cellular Rabies Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Human Diploid Cellular Rabies Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Human Diploid Cellular Rabies Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Human Diploid Cellular Rabies Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Human Diploid Cellular Rabies Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Human Diploid Cellular Rabies Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Human Diploid Cellular Rabies Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Chengdu Kanghua Basic Information, Human Diploid Cellular Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Chengdu Kanghua Human Diploid Cellular Rabies Vaccine Product Portfolios and Specifications
Table 80. Chengdu Kanghua Human Diploid Cellular Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Chengdu Kanghua Main Business
Table 82. Chengdu Kanghua Latest Developments
Table 83. Wyeth Laboratories Basic Information, Human Diploid Cellular Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Wyeth Laboratories Human Diploid Cellular Rabies Vaccine Product Portfolios and Specifications
Table 85. Wyeth Laboratories Human Diploid Cellular Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Wyeth Laboratories Main Business
Table 87. Wyeth Laboratories Latest Developments
Table 88. Beijing Kangtai Biology Basic Information, Human Diploid Cellular Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Beijing Kangtai Biology Human Diploid Cellular Rabies Vaccine Product Portfolios and Specifications
Table 90. Beijing Kangtai Biology Human Diploid Cellular Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Beijing Kangtai Biology Main Business
Table 92. Beijing Kangtai Biology Latest Developments
Table 93. Sanofi Pasteur SA Basic Information, Human Diploid Cellular Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Pasteur SA Human Diploid Cellular Rabies Vaccine Product Portfolios and Specifications
Table 95. Sanofi Pasteur SA Human Diploid Cellular Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Sanofi Pasteur SA Main Business
Table 97. Sanofi Pasteur SA Latest Developments
Table 98. Merieux Institute Basic Information, Human Diploid Cellular Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Merieux Institute Human Diploid Cellular Rabies Vaccine Product Portfolios and Specifications
Table 100. Merieux Institute Human Diploid Cellular Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Merieux Institute Main Business
Table 102. Merieux Institute Latest Developments
Table 103. Kanghua Biology Basic Information, Human Diploid Cellular Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Kanghua Biology Human Diploid Cellular Rabies Vaccine Product Portfolios and Specifications
Table 105. Kanghua Biology Human Diploid Cellular Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Kanghua Biology Main Business
Table 107. Kanghua Biology Latest Developments
List of Figures
Figure 1. Picture of Human Diploid Cellular Rabies Vaccine
Figure 2. Human Diploid Cellular Rabies Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Diploid Cellular Rabies Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Human Diploid Cellular Rabies Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Human Diploid Cellular Rabies Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 0.5ml
Figure 10. Product Picture of 1ml
Figure 11. Global Human Diploid Cellular Rabies Vaccine Sales Market Share by Type in 2022
Figure 12. Global Human Diploid Cellular Rabies Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Human Diploid Cellular Rabies Vaccine Consumed in Hospital
Figure 14. Global Human Diploid Cellular Rabies Vaccine Market: Hospital (2018-2023) & (K Units)
Figure 15. Human Diploid Cellular Rabies Vaccine Consumed in Clinic
Figure 16. Global Human Diploid Cellular Rabies Vaccine Market: Clinic (2018-2023) & (K Units)
Figure 17. Global Human Diploid Cellular Rabies Vaccine Sales Market Share by Application (2022)
Figure 18. Global Human Diploid Cellular Rabies Vaccine Revenue Market Share by Application in 2022
Figure 19. Human Diploid Cellular Rabies Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global Human Diploid Cellular Rabies Vaccine Sales Market Share by Company in 2022
Figure 21. Human Diploid Cellular Rabies Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Human Diploid Cellular Rabies Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Human Diploid Cellular Rabies Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Human Diploid Cellular Rabies Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Human Diploid Cellular Rabies Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas Human Diploid Cellular Rabies Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Human Diploid Cellular Rabies Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC Human Diploid Cellular Rabies Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Human Diploid Cellular Rabies Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe Human Diploid Cellular Rabies Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Human Diploid Cellular Rabies Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Human Diploid Cellular Rabies Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Human Diploid Cellular Rabies Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Human Diploid Cellular Rabies Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Human Diploid Cellular Rabies Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Human Diploid Cellular Rabies Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Human Diploid Cellular Rabies Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Human Diploid Cellular Rabies Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Human Diploid Cellular Rabies Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Human Diploid Cellular Rabies Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Human Diploid Cellular Rabies Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Human Diploid Cellular Rabies Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Human Diploid Cellular Rabies Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Human Diploid Cellular Rabies Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Human Diploid Cellular Rabies Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Human Diploid Cellular Rabies Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Human Diploid Cellular Rabies Vaccine
Figure 72. Industry Chain Structure of Human Diploid Cellular Rabies Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Human Diploid Cellular Rabies Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Human Diploid Cellular Rabies Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Human Diploid Cellular Rabies Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Human Diploid Cellular Rabies Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Human Diploid Cellular Rabies Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Human Diploid Cellular Rabies Vaccine Revenue Market Share Forecast by Application (2024-2029)